Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry

Toxicon

Volumn 43, Issue 2, 2004, Pages 173-183

  Davies, Noel W ^a   Wiese, Michael D ^b   Brown, Simon G A ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

Heterodimer; Jumper ant venom; LC MS; Myr p 1; Myr p 2; Myrmecia pilosula; Pilosulins

Indexed keywords

ANT VENOM; GLYCINE; IMMUNOGLOBULIN E; INSECT PROTEIN; ISOLEUCINE; PILOSULIN 1; PILOSULIN 2; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; DISULFIDE BOND; ELECTROSTIMULATION; IMMUNOTHERAPY; MOLECULAR STABILITY; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANT VENOMS; ANTS; AUSTRALIA; CHROMATOGRAPHY, LIQUID; INSECT PROTEINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; ORGANOPHOSPHORUS COMPOUNDS; PEPTIDES; SEQUENCE ANALYSIS, PROTEIN;

FORMICIDAE; MYRMECIA PILOSULA;

EID: 1442286366     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2003.11.021     Document Type: Article

References (30)

1. Brown S.G., Wu Q.X., Kelsall G.R., Heddle R.J., Baldo B.A. Fatal anaphylaxis following jack jumper ant sting in southern Tasmania. Medical Journal of Australia. (11-12):2001;644-647.
2. Brown S.G., Franks R.W., Baldo B.A., Heddle R.J. Prevalence, severity and natural history of jack jumper ant venom allergy in Tasmania. Journal of Allergy and Clinical Immunology. 111:2003;187-192.
3. Brown S.G., Wiese M.D., Blackman K.E., Heddle R.J. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover therapy. Lancet. 361:2003;1001-1006.
4. Clarke P.S. The natural history of sensitivity to jack jumper ants (Hymenoptera, formicidae, Myrmecia pilosula) in Tasmania. Medical Journal of Australia. (11-12):1986;564-566.
5. Crosland M.W.J., Crozier R.H., Imai H.T. Evidence for several sibling biological species centred on Myrmecia pilosula (F. Smith) (Hymenoptera: Formicidae). Journal of the Australian Entomological Society. 27:1988;13-14.
6. Crozier R.H., Dobric N., Imai H.T., Graur D., Cornuet J.M., Taylor R.W. Mitochondrial-DNA sequence evidence on the phylogeny of Australian jack-jumper ants of the Myrmecia pilosula complex. Molecular Phylogenetics and Evolution. 4:1995;20-30.
7. Dongre A.R., Jones J.L., Somogyi A., Wysocki V.H. Influence of peptide composition, gas-phase basicity, and chemical modification on fragmentation efficiency: evidence for the mobile proton model. Journal of the American Chemical Society. 118:(35):1996;8365-8374.
8. Donovan G.R., Baldo B.A. Pilosulin 2 from ant venom, cloning and expression of a cDNA encoding it and its antihypertensive properties. PCT International Application. 1997;27. Patent No. WO 9713854.
9. Donovan G.R., Baldo B.A., Sutherland S. Molecular cloning and characterization of a major allergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula. Biochimica et Biophysica. 1171:(3):1993;272-280.
10. Donovan G.R., Street M.D., Baldo B.A., Alewood P., Alewood D., Sutherland S. Identification of an IgE-binding determinant of the major allergen Myr p I from the venom of the Australian jumper ant Myrmecia pilosula. Biochimica et Biophysica Acta. (1):1994;48-52.
11. Donovan G.R., Street M.D., Baldo B.A. Separation of jumper ant (Myrmecia pilosula) venom allergens: a novel group of highly basic proteins. Electrophoresis. (5):1995;804-810.
12. Donovan G.R., Street M.D., Tetaz T., Smith A.I., Alewood D., Alewood P., Sutherland S.K., Baldo B.A. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products. Biochemistry and Molecular Biology International. (5):1996;877-885.
13. Douglas R., Weiner J., Abrahamson M., O'Hehir R. Prevalence of severe ant venom allergy in southeastern Australia. The Journal of Allergy and Clinical Immunology. 101:1998;129-131.
14. Ford S.A., Baldo B.A., Weiner J., Sutherland S. Identification of jack-jumper ant (Myrmecia pilosula) venom allergens. Clinical Experimental Allergy. 21:1991;167-171.
15. van Halteren H.K., van der Linden P.W., Burgers S.A., Bertelink A.K. Hymenoptera sting challenge of 348 patients: relation to subsequent field stings. Journal of Allergy and Clinical Immunology. 97:(5):1996;1058-1063.
16. Hink W.F., Pappas P.W., Jaworski D.C. Partial biochemical characterization of venom from the ant, Pseudomyrmex triplarinus. Toxicon. (7):1994;763-772.
17. Iavarone A.T., Jurchen J.C., Williams E.R. Supercharged protein and peptide ions formed by electrospray ionization. Analytical Chemistry. (7):2001;1455-1460.
18. King T.P., Hoffman D., Lowenstein H., Marsh D.G., Platts-Mills T.A., Thomas W. Allergen nomenclature. Allergy. 50:(9):1995;765-774.
19. King M.A., Wu Q.X., Donovan G.R., Baldo B.A. Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1. Cytometry. (4):1998;268-273.
20. Matuszek M.A., Hodgson W.C., Sutherland S.K., King R.G. Pharmacological studies of jumper ant (Myrmecia pilosula) venom: evidence for the presence of histamine, and haemolytic and eicosanoid-releasing factors. Toxicon. 30:(9):1992;1081-1091.
21. Matuszek M.A., Hodgson W.C., King R.G., Sutherland S.K. Some enzymic activities of two Australian ant venoms: a jumper ant Myrmecia pilosula and a bulldog ant Myrmecia pyriformis. Toxicon. 32:(12):1994;1543-1549.
22. Ogata K., Taylor R.W. Ants of the genus Myrmecia Fabricius; a preliminary review and key to the named species (Hymenoptera: Formidicae: Myrmeciinae). Journal of Natural History. 25:1991;1623-1673.
23. Orivel J., Redeker V., Le Caer J.P., Krier F., Revol-Junelles A.M., Longeon A., Chaffotte A., Dejean A., Rossier J. Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Journal of Biological Chemistry. 276:(21):2001;17823-17829.
24. Pan J., Hink W.F. Isolation and characterization of myrmexins, six isoforms of venom proteins with anti-inflammatory activity from the tropical ant, Pseudomyrmex triplarinus. Toxicon. 38:(10):2000;1403-1413.
25. Roepstorff P., Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry. 11:(11):1984;601.
26. Street M.D., Donovan G.R., Baldo B.A. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence. Biochimica et Biophysica Acta. 1305:(1/2):1996;87-97.
27. Tang X.J., Thibault P., Boyd R.K. Fragmentation reactions of multiply-protonated peptides and implications for sequencing by tandem mass spectrometry with low-energy collision-induced dissociation. Analytical Chemistry. 65:(20):1993;2824-2834.
28. Taylor R.W. Notes on Australian Bulldog Ants (Mymecia) and their Biology. Baldo B.A., Harle D.G. Proceedings of the Sydney Allergy Group. 1988;62-69 University of Sydney.
29. Wu, Q.X. 2001. Immunobiology of peptides from the venom of the jumper ant Myrmecia pilosula. PhD thesis, University of Sydney.
30. Wu Q.X., King M.A., Donovan G.R., Alewood D., Alewood P., Sawyer W.H., Baldo B. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula. Biochimica et Biophysica Acta. 1425:(1):1998;74-80.